Literature DB >> 17440034

Adipose tissue distribution in relation to insulin resistance in type 2 diabetes mellitus.

Koichiro Azuma1, Leonie K Heilbronn, Jeanine B Albu, Steven R Smith, Eric Ravussin, David E Kelley.   

Abstract

Insulin resistance (IR) is typically more severe in obese individuals with type 2 diabetes (T2DM) than in similarly obese non-diabetics but whether there are group differences in body composition and whether such differences contribute to the more severe IR of T2DM is uncertain. DEXA and regional CT imaging were conducted to assess adipose tissue (AT) distribution and fat content in liver and muscle in 67 participants with T2DM (F39/M28, age 60 +/- 7 yr, BMI 34 +/- 3 kg/m(2)) and in 35 similarly obese, non-DM volunteers (F20/M15, age 55 +/- 8 yr, BMI 33 +/- 2 kg/m(2)). A biopsy of subcutaneous abdominal AT was done to measure adipocyte size. A glucose clamp was performed at an insulin infusion of 80 mU x min(-1) x m(-2). There was more severe IR in T2DM (6.1 +/- 2.3 vs. 9.9 +/- 3.3 mg x min(-1) x kg FFM(-1); P < 0.01). Group comparisons of body composition parameters was performed after adjusting for the effect of age, gender, race, height and total fat mass (FM). T2DM was associated with less leg FM (-1.2 +/- 0.4 kg, P < 0.01), more trunk FM (+1.1 +/- 0.4 kg, P < 0.05), greater hepatic fat (P < 0.05), and more subfascial adipose tissue around skeletal muscle (P < 0.05). There was a significant group x sex interaction for VAT (P < 0.01), with greater VAT in women with T2DM (P < 0.01). Mean adipocyte size (AS) did not significantly differ across groups, and smaller AS was associated with increased leg FM, whereas larger AS was related to more trunk FM (both P < 0.05). Group differences in IR were less after adjusting for group differences in leg FM, trunk FM, and hepatic fat, but these adjustments only partially accounted for the greater severity of IR in T2DM. In summary, T2DM, compared with similarly obese nondiabetic men and women, is associated with less leg FM and greater trunk FM and hepatic fat.

Entities:  

Mesh:

Year:  2007        PMID: 17440034      PMCID: PMC5684697          DOI: 10.1152/ajpendo.00394.2006

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  44 in total

1.  Intramuscular lipid content is increased in obesity and decreased by weight loss.

Authors:  B H Goodpaster; R Theriault; S C Watkins; D E Kelley
Journal:  Metabolism       Date:  2000-04       Impact factor: 8.694

2.  The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations : distinct metabolic effects of two fat compartments.

Authors:  Miriam Cnop; Melinda J Landchild; Josep Vidal; Peter J Havel; Negar G Knowles; Darcy R Carr; Feng Wang; Rebecca L Hull; Edward J Boyko; Barbara M Retzlaff; Carolyn E Walden; Robert H Knopp; Steven E Kahn
Journal:  Diabetes       Date:  2002-04       Impact factor: 9.461

3.  Skeletal muscle triglyceride levels are inversely related to insulin action.

Authors:  D A Pan; S Lillioja; A D Kriketos; M R Milner; L A Baur; C Bogardus; A B Jenkins; L H Storlien
Journal:  Diabetes       Date:  1997-06       Impact factor: 9.461

4.  Waist and hip circumferences have independent and opposite effects on cardiovascular disease risk factors: the Quebec Family Study.

Authors:  J C Seidell; L Pérusse; J P Després; C Bouchard
Journal:  Am J Clin Nutr       Date:  2001-09       Impact factor: 7.045

5.  Subdivisions of subcutaneous abdominal adipose tissue and insulin resistance.

Authors:  D E Kelley; F L Thaete; F Troost; T Huwe; B H Goodpaster
Journal:  Am J Physiol Endocrinol Metab       Date:  2000-05       Impact factor: 4.310

6.  Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes.

Authors:  Donna H Ryan; Mark A Espeland; Gary D Foster; Steven M Haffner; Van S Hubbard; Karen C Johnson; Steven E Kahn; William C Knowler; Susan Z Yanovski
Journal:  Control Clin Trials       Date:  2003-10

7.  Early and late stimulation of ob mRNA expression in meal-fed and overfed rats.

Authors:  R B Harris; T G Ramsay; S R Smith; R C Bruch
Journal:  J Clin Invest       Date:  1996-05-01       Impact factor: 14.808

8.  Skeletal muscle density: effects of obesity and non-insulin-dependent diabetes mellitus.

Authors:  D E Kelley; B S Slasky; J Janosky
Journal:  Am J Clin Nutr       Date:  1991-09       Impact factor: 7.045

9.  Trunk fat and leg fat have independent and opposite associations with fasting and postload glucose levels: the Hoorn study.

Authors:  Marieke B Snijder; Jacqueline M Dekker; Marjolein Visser; Lex M Bouter; Coen D A Stehouwer; John S Yudkin; Robert J Heine; Giel Nijpels; Jacob C Seidell
Journal:  Diabetes Care       Date:  2004-02       Impact factor: 19.112

10.  Testosterone concentrations in women and men with NIDDM.

Authors:  B Andersson; P Mårin; L Lissner; A Vermeulen; P Björntorp
Journal:  Diabetes Care       Date:  1994-05       Impact factor: 19.112

View more
  33 in total

1.  Designing Phase II B trials in sarcopenia: the best target population.

Authors:  M Pahor; M Cesari
Journal:  J Nutr Health Aging       Date:  2011-08       Impact factor: 4.075

2.  A family history of type 2 diabetes increases risk factors associated with overfeeding.

Authors:  D Samocha-Bonet; L V Campbell; A Viardot; J Freund; C S Tam; J R Greenfield; L K Heilbronn
Journal:  Diabetologia       Date:  2010-05-12       Impact factor: 10.122

3.  Prediction of Android and Gynoid Body Adiposity via a Three-dimensional Stereovision Body Imaging System and Dual-Energy X-ray Absorptiometry.

Authors:  Jane J Lee; Jeanne H Freeland-Graves; M Reese Pepper; Philip R Stanforth; Bugao Xu
Journal:  J Am Coll Nutr       Date:  2015-04-27       Impact factor: 3.169

Review 4.  Adipose tissue heterogeneity: implication of depot differences in adipose tissue for obesity complications.

Authors:  Mi-Jeong Lee; Yuanyuan Wu; Susan K Fried
Journal:  Mol Aspects Med       Date:  2012-10-13

5.  Metabolic changes following a 1-year diet and exercise intervention in patients with type 2 diabetes.

Authors:  Jeanine B Albu; Leonie K Heilbronn; David E Kelley; Steven R Smith; Koichiro Azuma; Evan S Berk; F Xavier Pi-Sunyer; Eric Ravussin
Journal:  Diabetes       Date:  2009-12-22       Impact factor: 9.461

Review 6.  Target population for clinical trials on sarcopenia.

Authors:  M Cesari; M Pahor
Journal:  J Nutr Health Aging       Date:  2008 Aug-Sep       Impact factor: 4.075

7.  Disruption of the sugar-sensing receptor T1R2 attenuates metabolic derangements associated with diet-induced obesity.

Authors:  Kathleen R Smith; Tania Hussain; Elnaz Karimian Azari; Jennifer L Steiner; Julio E Ayala; Richard E Pratley; George A Kyriazis
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-02-16       Impact factor: 4.310

8.  Skeletal muscle and organ masses differ in overweight adults with type 2 diabetes.

Authors:  Lance E Davidson; David E Kelley; Stanley Heshka; John Thornton; F Xavier Pi-Sunyer; Lawrence Boxt; Ashok Balasubramanyam; Dympna Gallagher
Journal:  J Appl Physiol (1985)       Date:  2014-06-19

9.  Obesity and Insulin Resistance Are Inversely Associated with Serum and Adipose Tissue Carotenoid Concentrations in Adults.

Authors:  Ayelet Harari; Adelle C F Coster; Arthur Jenkins; Aimin Xu; Jerry R Greenfield; Dror Harats; Aviv Shaish; Dorit Samocha-Bonet
Journal:  J Nutr       Date:  2020-01-01       Impact factor: 4.798

Review 10.  Viewpoints on the way to the consensus session: where does insulin resistance start? The adipose tissue.

Authors:  Patricia Iozzo
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.